...
首页> 外文期刊>Clinical rheumatology >The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients
【24h】

The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients

机译:CD40多态性(RS1883832C / T)和可溶性CD40与埃及患者系统狼疮红斑狼疮风险的关联

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundSystemic lupus erythematosus (SLE) is a complex autoimmune disorder of unknown etiology. Considerable evidence supports a genetic basis for susceptibility to SLE. Genetic and functional data suggested the CD40 receptor (CD40) and CD40 ligand (CD40L) as strong candidate genes for SLE.AimTo investigate whether CD40 gene rs1883832 C/T single-nucleotide polymorphism (SNP) and/or soluble CD40 (sCD40) are associated with SLE in the Egyptian population.Subjects and methodsThe study included a hundred SLE patients, and a fifty age- and gender-matched healthy control subjects. CD40 gene rs1883832 C/T genotyping was carried out using restriction fragment length polymorphism (RFLP), while sCD40 levels were measured by ELISA.ResultsCD40 rs1883832C/T genotypes (CC, TT, and CT) as well as CD40 alleles (C and T) did not differ between SLE patients and normal control (p=0.63, 0.37, and 0.31 respectively). Though did not reach statistical significance, carriers of genotype CT had 1.5 times more chance to develop SLE compared to wild homozygous CC genotype carriers (OR 1.44), while carriers of genotype TT had similar to 2 times more chance to have SLE than CC carries (OR 1.96). Accordingly, the carriers of the T allele had not sign1.5 times more chance to get SLE compared to the carriers of the C allele (OR 1.4). The serum sCD40 level was significantly higher in SLE patients compared to healthy control (3.4 vs. 0.8ng/mL, p<0.001). In SLE patients, using CC as the reference genotype, serum sCD40 level was significantly higher in the carriers of the homozygous genotype TT (3.81.3 vs. 2.9 +/- 1.9, p=0.0001), and T allele (3.6 +/- 1.4 vs. 3.0 +/- 1.5, p=0.003). Moreover, sCD40 could discriminate SLE patients from normal subjects at a cutoff value of 0.885ng/mL with 98% sensitivity and 96% specificity (AUC=0.999, p<0.001).Conclusions p id=Par5 The study did not prove CD40 gene (rs1883832 C/T) polymorphism as a clear risk factor of SLE in this cohort of Egyptian patients, though it was highly likely associated with the carriers of T allele. In the same context, significant high sCD40 levels were observed in the T allele carriers.
机译:Backgroundssystemic狼疮(SLO)是一种复杂的自身免疫障碍未知病因。相当大的证据支持遗传基础,以易感易感。遗传和功能数据表明CD40受体(CD40)和CD40配体(CD40L)作为SLE.aimTO的强候选基因,研究CD40基因RS1883832C / T单核苷酸多态性(SNP)和/或可溶性CD40(SCD40)是相关的在埃及人的人口中,有一个和方法,研究包括一百个SLE患者,以及五十岁和性别匹配的健康对照受试者。使用限制性片段长度多态性(RFLP)进行CD40基因RS1883832 C / T基因分型,而ELISA.ResultSCD40 RS1883832C / T基因型(CC,TT和CT)以及CD40等位基因(C和T)测量SCD40水平。 SLE患者与正常对照之间没有差异(P = 0.63,0.37和0.31)。虽然没有达到统计学意义,但与野生纯合CC基因型载体(或1.44)相比,基因型CT的载体有1.5倍的机会,而基因型TT的载体与SLIS的载体相似,而不是CC携带的机会(或1.96)。因此,与C等位基因(或1.4)的载体相比,T等位基因的载体没有更多的机会使SLE相比(或1.4)。与健康对照相比,SLE患者血清SCD40水平显着较高(3.4 vs.0.8ng / ml,p <0.001)。在SLE患者中,使用CC作为参考基因型,纯合基因型TT的载体(3.81.3与2.9 +/- 1.9,P = 0.0001)和T等位基因(3.6 +/- 1.4与3.0 +/- 1.5,p = 0.003)。此外,SCD40可以以98%的敏感度和96%的特异性(AUC = 0.999,P <0.001),在0.885ng / ml的截止值下区分SLE患者的截止值0.885ng / ml,P <0.001)。CONCLUSIONS P ID = PAR5该研究没有证明CD40基因( RS1883832 C / T)多态性作为埃及患者队列的SLE清晰的风险因素,尽管它很可能与T等位基因的载体有关。在相同的情况下,在T等位基因载体中观察到显着的高SCD40水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号